Paracrine effects of mesenchymal stem cells-conditioned medium on microglial cytokines expression and nitric oxide production

NeuroImmunoModulation

Volumn 22, Issue 4, 2015, Pages 233-242

  Ooi, Yin Yin ^a   Dheen, S Thameem ^a   Sam Wah Tay, Samuel ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Conditioned medium; Cytokines; Mesenchymal stem cells; Microglia

Indexed keywords

BETA1 INTEGRIN; CD11B ANTIGEN; CD146 ANTIGEN; CD45 ANTIGEN; CYTOKINE; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE; STEM CELL ANTIGEN 1; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; CULTURE MEDIUM;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL ACTIVATION; CONTROLLED STUDY; IMMUNOFLUORESCENCE; MALE; MESENCHYMAL STEM CELL; MICROGLIA; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; BRAIN CORTEX; C57BL MOUSE; CULTURE MEDIUM; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

ANIMALS; CEREBRAL CORTEX; CULTURE MEDIA, CONDITIONED; CYTOKINES; MALE; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; MICROGLIA; NITRIC OXIDE; PARACRINE COMMUNICATION;

EID: 84928415835     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000365483     Document Type: Article

References (51)

1. Ousman SS, Kubes P: Immune surveillance in the central nervous system. Nat Neurosci 2012; 15: 1096-1101.
2. Block ML, Hong JS: Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 2005; 76: 77-98.
3. Aloisi F: Immune function of microglia. Glia 2001; 36: 165-179.
4. Kreutzberg GW: Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996; 19: 312-318.
5. Huo Y, Rangarajan P, Ling EA, Dheen ST: Dexamethasone inhibits the Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia. BMC Neurosci 2011; 12: 49.
6. Zhou Y, Ling EA, Dheen ST: Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia. J Neurochem 2007; 102: 667-678.
7. Zhu C, Xiong Z, Chen X, Peng F, Hu X, Chen Y, Wang Q: Artemisinin attenuates lipopolysaccharide-stimulated proinflammatory responses by inhibiting NF-kappaB pathway in microglia cells. PLoS One 2012; 7:e35125.
8. da Silva Meirelles L, Chagastelles PC, Nardi NB: Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119: 2204-2213.
9. Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh K, Bae YC, Jung JS: Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004; 14: 311-324.
10. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH: Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004; 103: 1669-1675.
11. Muller I, Lymperi S, Dazzi F: Mesenchymal stem cell therapy for degenerative inflammatory disorders. Curr Opin Organ Transplant 2008; 13: 639-644.
12. Uccelli A, Moretta L, Pistoia V: Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8: 726-736.
13. Lee HJ, Lee JK, Lee H, Carter JE, Chang JW, Oh W, Yang YS, Suh JG, Lee BH, Jin HK, Bae JS: Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation. Neurobiol Aging 2012; 33: 588-602.
14. Sun H, Benardais K, Stanslowsky N, Thau-Habermann N, Hensel N, Huang D, Claus P, Dengler R, Stangel M, Petri S: Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in amyotrophic lateral sclerosis (ALS)-in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia. PLoS One 2013; 8:e72926.
15. Kim YJ, Park HJ, Lee G, Bang OY, Ahn YH, Joe E, Kim HO, Lee PH: Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia 2009; 57: 13-23.
16. Giunti D, Parodi B, Usai C, Vergani L, Casazza S, Bruzzone S, Mancardi G, Uccelli A: Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1. Stem Cells 2012; 30: 2044-2053.
17. Ooi YY, Ramasamy R, Rahmat Z, Subramaiam H, Tan SW, Abdullah M, Israf DA, Vidyadaran S: Bone marrow-derived mesenchymal stem cells modulate BV2 microglia responses to lipopolysaccharide. Int Immunopharmacol 2010; 10: 1532-1540.
18. Rahmat Z, Jose S, Ramasamy R, Vidyadaran S: Reciprocal interactions of mouse bone marrow-derived mesenchymal stem cells and BV2 microglia after lipopolysaccharide stimulation. Stem Cell Res Ther 2013; 4: 12.
19. Barker RA, Widner H: Immune problems in central nervous system cell therapy. NeuroRx 2004; 1: 472-481.
20. Emborg ME, Zhang Z, Joers V, Brunner K, Bondarenko V, Ohshima S, Zhang SC: Intracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeys. Cell Transplant 2013; 22: 831-838.
21. Saura J, Tusell JM, Serratosa J: High-yield isolation of murine microglia by mild trypsinization. Glia 2003; 44: 183-189.
22. Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F: Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol 1990; 27: 229-237.
23. Schmittgen TD, Livak KJ: Analyzing realtime PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-1108.
24. Waetzig V, Czeloth K, Hidding U, Mielke K, Kanzow M, Brecht S, Goetz M, Lucius R, Herdegen T, Hanisch UK: c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia 2005; 50: 235-246.
25. Trounson A, Thakar RG, Lomax G, Gibbons D: Clinical trials for stem cell therapies. BMC Med 2011; 9: 52.
26. Singer NG, Caplan AI: Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol 2011; 6: 457-478.
27. Rafei M, Campeau PM, Aguilar-Mahecha A, Buchanan M, Williams P, Birman E, Yuan S, Young YK, Boivin MN, Forner K, et al: Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. J Immunol 2009; 182: 5994-6002.
28. Karussis D, Kassis I, Kurkalli BG, Slavin S: Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/ neurodegenerative diseases. J Neurol Sci 2008; 265: 131-135.
29. Nikolic WV, Hou H, Town T, Zhu Y, Giunta B, Sanberg CD, Zeng J, Luo D, Ehrhart J, Mori T, et al: Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice. Stem Cells Dev 2008; 17: 423-439.
30. Sarojini H, Estrada R, Lu H, Dekova S, Lee MJ, Gray RD, Wang E: PEDF from mouse mesenchymal stem cell secretome attracts fibroblasts. J Cell Biochem 2008; 104: 1793-1802.
31. Walter MN, Wright KT, Fuller HR, MacNeil S, Johnson WE: Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays. Exp Cell Res 2010; 316: 1271-1281.
32. Fouraschen SM, Pan Q, de Ruiter PE, Farid WR, Kazemier G, Kwekkeboom J, Ijzermans JN, Metselaar HJ, Tilanus HW, de Jonge J, van der Laan LJ: Secreted factors of human liverderived mesenchymal stem cells promote liver regeneration early after partial hepatectomy. Stem Cells Dev 2012; 21: 2410-2419.
33. Timmers L, Lim SK, Hoefer IE, Arslan F, Lai RC, van Oorschot AA, Goumans MJ, Strijder C, Sze SK, Choo A, et al: Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res 2011; 6: 206-214.
34. Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW, Yarmush ML: Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2007; 2:e941.
35. Ling EA, Ng YK, Wu CH, Kaur C: Microglia: its development and role as a neuropathology sensor. Prog Brain Res 2001; 132: 61-79.
36. Stansley B, Post J, Hensley K: A comparative review of cell culture systems for the study of microglial biology in Alzheimer's disease. J Neuroinflammation 2012; 9: 115.
37. Giulian D, Baker TJ: Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 1986; 6: 2163-2178.
38. Wieseler-Frank J, Maier SF, Watkins LR: Central proinflammatory cytokines and pain enhancement. Neurosignals 2005; 14: 166-174.
39. Lee JK, Jin HK, Endo S, Schuchman EH, Carter JE, Bae JS: Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells 2010; 28: 329-343.
40. Zhang R, Liu Y, Yan K, Chen L, Chen XR, Li P, Chen FF, Jiang XD: Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflammation 2013; 10: 106.
41. Kleinert H, Pautz A, Linker K, Schwarz PM: Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 2004; 500: 255-266.
42. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y: Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008; 2: 141-150.
43. Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, Muroi K, Ozawa K: Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 2007; 109: 228-234.
44. Gibbons HM, Dragunow M: Microglia induce neural cell death via a proximity-dependent mechanism involving nitric oxide. Brain Res 2006; 1084: 1-15.
45. Wink DA, Mitchell JB: Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 1998; 25: 434-456.
46. Munoz-Fernandez MA, Fresno M: The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol 1998; 56: 307-340.
47. Peunova N, Kuzin B, Roberts I, O'Kane C, Enikolopov G: Nitric oxide, cell multiplication, and cell survival. Cold Spring Harb Symp Quant Biol 1996; 61: 417-426.
48. Magnusson S, Alm P, Kanje M: Inducible nitric oxide synthase increases in regenerating rat ganglia. Neuroreport 1996; 7: 2046-2050.
49. Demerle-Pallardy C, Lonchampt MO, Chabrier PE, Braquet P: Nitric oxide synthase induction in glial cells: effect on neuronal survival. Life Sci 1993; 52: 1883-1890.
50. Cipriani R, Villa P, Chece G, Lauro C, Paladini A, Micotti E, Perego C, De Simoni MG, Fredholm BB, Eusebi F, Limatola C: CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. J Neurosci 2011; 31: 16327-16335.
51. Gaetani P, Pisano P, Solinas G, Colombo P, Destro A, Levi D, Aimar E, Rodriguez R, Baena Y, Allavena P: Immunohistohemical expression of the chemokine fractalkine and its receptor in the human brain cortex after severe traumatic brain injury and brain hemorrhage. J Neurosurg Sci 2013; 57: 55-62.